Delphine Imbert, Chief Technology Officer
Professional Overview
Delphine Imbert is a seasoned biotechnology executive with over 20 years of experience in pharmaceutical sciences, manufacturing, and operations. As the Chief Technology Officer at Pliant Therapeutics, she is responsible for leading the company's technology strategy, overseeing research and development, and driving innovation to support the development of novel therapeutics.
Experience Summary
Current Role
As the Chief Technology Officer at Pliant Therapeutics since 2025, Delphine is responsible for spearheading the company's technological vision and ensuring the successful execution of its research and development initiatives. She oversees a talented team of scientists and engineers, fostering a culture of collaboration and continuous improvement to accelerate the advancement of Pliant's pipeline.
Career Progression
Prior to her current role, Delphine held several leadership positions in the biotechnology industry. She served as the SVP of CMC and Tech Ops at Chinook Therapeutics, where she led the company's manufacturing and technical operations, and as the SVP of Pharmaceutical Sciences at Dermira, Inc., where she played a pivotal role in the development and commercialization of several dermatological products.
Delphine's career also includes experience as a mentor and advocate for diversity and inclusion. She founded the MentoreD program at Dermira, which provided mentorship and professional development opportunities for underrepresented individuals in the industry. Additionally, she served as the Founder and Executive Sponsor of the Culture Team at Dermira, driving initiatives to foster a positive and inclusive work environment.
Academic Background
Delphine holds a Ph.D. in Pharmaceutical Sciences from the University of California, San Francisco, where she specialized in drug delivery and formulation development. Her academic achievements include numerous publications in peer-reviewed journals and recognition for her contributions to the field.
Areas of Expertise
- Pharmaceutical Sciences and Drug Development
- Manufacturing and Technical Operations
- Research and Development
- Strategic Technology Planning
- Cross-functional Team Leadership
- Mentorship and Diversity Initiatives
Professional Impact
Throughout her career, Delphine has demonstrated a strong track record of driving innovation and leading successful product development initiatives. At Chinook Therapeutics, she played a key role in the successful advancement of the company's pipeline, contributing to the development of several investigational therapies. At Dermira, she was instrumental in the commercialization of multiple dermatological products, positively impacting patient outcomes.
Conclusion
Delphine Imbert's extensive experience, technical expertise, and commitment to fostering a collaborative and inclusive work environment position her as a valuable asset to Pliant Therapeutics. As the Chief Technology Officer, she is poised to continue driving the company's technological advancements and supporting the development of innovative therapies that address unmet medical needs.
